Metrovacesa (MVC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
18 Feb, 2026Executive summary
Revenues grew 42% year-over-year in H1 2024 to €235 million, driven by robust residential sales and improved margins.
EBITDA rose to €31.3 million (+223% YoY), with net profit at €3.83 million, reversing a prior-year loss.
Delivered 675 residential units (+18% YoY), with a gross margin of 24.2% and average selling price of €335,000 per unit (+17% YoY).
Sales backlog reached €1.2 billion (3,700+ units), providing strong visibility for future cash flows.
ESG initiatives advanced, with all launches achieving high energy efficiency and comprehensive carbon analysis underway.
Financial highlights
H1 2024 revenues of €235 million (+42% YoY), with residential contributing €226.7 million and land sales €8.3 million.
Gross margin improved to 24.2%, the highest since 2018, and net margin rose to 19.4%.
EBITDA margin increased to 13.3% (from 5.9% in H1 2023); net profit was €3.8 million.
Free cash flow of €66.2 million; net debt at €343.4 million with a 13.8% loan-to-value ratio.
Dividend of €54.6 million (€0.36 per share) distributed in May 2024.
Outlook and guidance
On track to deliver more units in 2024 than in 2023, with a higher concentration of deliveries in H2.
FY2024 operating cash flow guidance reiterated at €100–125 million, supported by strong sales backlog and high pre-sales coverage for 2024–2026.
Gross margin guidance raised to 22–23% for the coming years.
Market outlook remains positive, with support from ECB rate cuts and stable Euribor.
Latest events from Metrovacesa
- Record 2025 results, high cash flow, strong dividend, and CEO pay up 8% with performance alignment.MVC
Q4 202527 Feb 2026 - 2024 saw record revenue, 2,000 units delivered, €15.9M profit, and €0.69/share dividends.MVC
Q4 202418 Feb 2026 - 9M25 revenues up, backlog and ASPs rise, dividend yield at 18%, cash flow outlook raised.MVC
Q3 202518 Feb 2026 - Robust demand and higher presales drive growth, with a €0.46 dividend approved.MVC
Q1 202518 Feb 2026 - H1 2025 delivered strong sales but lower margins and a net loss, with guidance reaffirmed.MVC
Q2 202518 Feb 2026 - Presales and backlog hit records, margins improved, and dividend yield reached 8.5%.MVC
Q3 202417 Jan 2026 - Dividend, director ratification, and delegation of powers all approved by a large majority.MVC
EGM 202413 Jan 2026